Akoya Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Aug '25 Aug 13, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2018 - 2019
Market Capitalization	5	8	4	18	68	-	Upgrade
Market Cap Growth	19.42%	72.37%	-75.26%	-73.20%	-	-	Upgrade
Enterprise Value	12	14	10	22	75	-	Upgrade
Last Close Price	1.30	48.75	100.75	540.63	2117.50	-	Upgrade
PE Ratio	0.30	19.45	0.98	2.91	14.76	-	Upgrade
Forward PE	-	0.73	17.68	80.09	-	-	Upgrade
PS Ratio	0.01	0.33	0.15	0.61	2.66	-	Upgrade
PB Ratio	0.00	0.18	0.13	0.60	2.55	-	Upgrade
P/TBV Ratio	0.11	0.18	0.13	0.62	2.65	-	Upgrade
P/OCF Ratio	-	-	-	-	16.72	-	Upgrade
EV/Sales Ratio	0.52	0.60	0.33	0.74	2.94	-	Upgrade
EV/EBITDA Ratio	4.14	4.80	1.41	3.26	13.32	-	Upgrade
EV/EBIT Ratio	6.59	7.64	1.63	3.37	13.88	-	Upgrade
Debt / Equity Ratio	0.17	0.17	0.12	0.18	0.13	0.73	Upgrade
Debt / EBITDA Ratio	2.51	2.51	0.61	0.80	0.59	2.18	Upgrade
Asset Turnover	0.44	0.44	0.70	0.81	0.83	0.81	Upgrade
Inventory Turnover	1.81	1.81	3.24	3.70	3.61	3.48	Upgrade
Quick Ratio	0.72	0.72	0.49	1.15	1.30	0.50	Upgrade
Current Ratio	2.42	2.42	2.52	2.21	2.20	0.93	Upgrade
Return on Equity (ROE)	0.91%	0.91%	13.84%	22.05%	24.55%	33.89%	Upgrade
Return on Assets (ROA)	2.16%	2.16%	8.85%	11.10%	10.96%	9.69%	Upgrade
Return on Capital (ROIC)	2.54%	2.54%	9.80%	12.51%	13.80%	12.91%	Upgrade
Return on Capital Employed (ROCE)	4.10%	4.10%	16.10%	21.40%	18.70%	25.70%	Upgrade
Earnings Yield	8.15%	5.14%	102.32%	34.35%	6.78%	-	Upgrade
FCF Yield	-158.25%	-99.84%	-15.89%	-27.11%	-0.64%	-	Upgrade
Buyback Yield / Dilution	-168.62%	-161.24%	-9.55%	-25.20%	-28.70%	-0.85%	Upgrade

Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q